2024
Large TRAPPC11 gene deletions as a cause of muscular dystrophy and their estimated genesis
KOPČILOVÁ, Johana, Hana PTÁČKOVÁ, Tereza KRAMÁŘOVÁ, Lenka FAJKUSOVÁ, Kamila RÉBLOVÁ et. al.Základní údaje
Originální název
Large TRAPPC11 gene deletions as a cause of muscular dystrophy and their estimated genesis
Autoři
KOPČILOVÁ, Johana (203 Česká republika, domácí), Hana PTÁČKOVÁ, Tereza KRAMÁŘOVÁ, Lenka FAJKUSOVÁ (203 Česká republika, domácí), Kamila RÉBLOVÁ (203 Česká republika, domácí), Jiří ZEMAN, Tomáš HONZÍK, Lucie ZDRAŽILOVÁ, Josef ZÁMEČNÍK, Patrícia BALÁŽOVÁ, Karin VIESTOVÁ, Miriam KOLNÍKOVÁ, Hana HANSÍKOVÁ a Jana ZÍDKOVÁ
Vydání
Journal of Medical Genetics, London, BMJ Publishing Group, 2024, 0022-2593
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30101 Human genetics
Stát vydavatele
Velká Británie a Severní Irsko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 4.000 v roce 2022
Organizační jednotka
Přírodovědecká fakulta
UT WoS
001272357400001
Klíčová slova česky
svalová dystrofie; variace počtu kopií
Klíčová slova anglicky
muscular dystrophy; copy-number variation
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 1. 10. 2024 09:54, Mgr. Marie Šípková, DiS.
Anotace
V originále
Background: Transport protein particle (TRAPP) is a multiprotein complex that functions in localising proteins to the Golgi compartment. The TRAPPC11 subunit has been implicated in diseases affecting muscle, brain, eye and to some extent liver. We present three patients who are compound heterozygotes for a missense variant and a structural variant in the TRAPPC11 gene. TRAPPC11 structural variants have not yet been described in association with a disease. In order to reveal the estimated genesis of identified structural variants, we performed sequencing of individual breakpoint junctions and analysed the extent of homology and the presence of repetitive elements in and around the breakpoints. Methods: Biochemical methods including isoelectric focusing on serum transferrin and apolipoprotein C-III, as well as mitochondrial respiratory chain complex activity measurements, were used. Muscle biopsy samples underwent histochemical analysis. Next-generation sequencing was employed for identifying sequence variants associated with neuromuscular disorders, and Sanger sequencing was used to confirm findings. Results: We suppose that non-homologous end joining is a possible mechanism of deletion origin in two patients and non-allelic homologous recombination in one patient. Analyses of mitochondrial function performed in patients' skeletal muscles revealed an imbalance of mitochondrial metabolism, which worsens with age and disease progression. Conclusion: Our results contribute to further knowledge in the field of neuromuscular diseases and mutational mechanisms. This knowledge is important for understanding the molecular nature of human diseases and allows us to improve strategies for identifying disease-causing mutations.
Návaznosti
LM2018132, projekt VaV |
| ||
NU21-06-00363, projekt VaV |
|